Protective effects of sildenafil citrate administration on cisplatin-induced ovarian damage in rats

Gynecological Endocrinology

Volumn 31, Issue 4, 2015, Pages 272-277

  Taskin, Mine Islimye ^a   Yay, Arzu ^b   Adali, Ertan ^a   Balcioglu, Esra ^b   Inceboz, Umit ^a  

^a BALIKESIR UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

AMH; Cisplatin; Primordial follicle; Sildenafil citrate

Indexed keywords

CISPLATIN; SILDENAFIL; SODIUM CHLORIDE; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; MUELLERIAN INHIBITING FACTOR; PHOSPHODIESTERASE V INHIBITOR; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CISPLATIN INDUCED OVARIAN DAMAGE; CONTROLLED STUDY; FEMALE; FERTILITY PRESERVATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; OVARY; OVARY DISEASE; OVARY FOLLICLE; PRIORITY JOURNAL; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; INFERTILITY, FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; OOCYTE DEVELOPMENT; PATHOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALS; ANTI-MULLERIAN HORMONE; ANTINEOPLASTIC AGENTS; BIOMARKERS; CISPLATIN; FEMALE; IMMUNOHISTOCHEMISTRY; INFERTILITY, FEMALE; INJECTIONS, INTRAPERITONEAL; OOGENESIS; OVARY; PHOSPHODIESTERASE 5 INHIBITORS; PROTECTIVE AGENTS; RANDOM ALLOCATION; RATS, WISTAR; SILDENAFIL CITRATE;

EID: 84931031056     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.984679     Document Type: Article

References (32)

1. Larsen EC, Muller J, Schmiegelow K, et al. Reduced ovarian function in long-term survivors of radiation-and chemotherapy treated childhood cancer. J Clin Endocrinol Metab 2003;88: 5307-14.
2. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251-6.
3. Huang YH, Zhao XJ, Zhang QH, Xin XY. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis. Gynecol Oncol 2009;112:409-14.
4. Ozcelik B, Turkyilmaz C, Ozgun MT, et al. Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropinreleasing hormone agonist. Fertil Steril 2010;93:1609-14.
5. Sverrisdottir A, Nystedt M, Johansson H, FornanderSverrisdottir T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat 2009;117:561-7.
6. Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist 2007; 12:1044-54.
7. Amin A, Buratovich MA. New platinum and ruthenium complexes-the latest class of potential chemotherapeutic drugs-a review of recent developments in the field. Mini Rev Med Chem 2009;9: 1489-503.
8. Ockaili R, Salloum F, Hawkins J, Kukreja RC. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol 2002;283:H1263-9.
9. Lee KW, Jeong JY, Lim BJ, et al. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology 2009;257:137-43.
10. Ali BH, Abdelrahman AM, Al-Salam S, et al. The effect of sildenafil on cisplatin nephrotoxicity in rats. Basic Clin Pharmacol Toxicol 2011;109:300-8.
11. Li X, Yang S, Lv X, et al. The mechanism of mesna in protection from cisplatin-induced ovarian damage in female rats. J Gynecol Oncol 2013;24:177-85.
12. Lee MM, Donahoe PK. Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 1993;14:152-64.
13. Fanchin R, Schonauer LM, Righini C, et al. Serum anti-mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003;18:323-7.
14. Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 2006; 131:1-9.
15. Iwase A, Nakamura T, Nakahara T, et al. Anti-Müllerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review. Reprod Sci 2014. [Epub ahead of print].
16. Yeh J, Kim B, Liang YJ, Peresie J. Mullerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage. Biochem Biophys Res Commun 2006;348:337-44.
17. Rosendahl M, Andersen CY, la Cour Freiesleben N, et al. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril 2010;94: 156-66.
18. Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 1999;14:1903-7.
19. Yucebilgin MS, Terek MC, Ozsaran A, et al. Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility. Aust N Z J Obstet Gynaecol 2004;44: 6-9.
20. Borovskaya TG, Goldberg VE, Fomina TI, et al. Morphological and functional state of rat ovaries in early and late periods after administration of platinum cytostatics. Bull Exp Biol Med 2004;137: 331-5.
21. Tan SJ, Yeh YC, Shang WJ, et al. Protective effect of a gonadotropin-releasing hormone analogue on chemotherapeutic agent-induced ovarian gonadotoxicity: a mouse model. Eur J Obstet Gynecol Reprod Biol 2010;149:182-5.
22. Lemos CN, Reis FM, Pena GN, et al. Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide. Reprod Biol Endocrinol 2010;8:51.
23. Palipoch S, Punsawad C. Biochemical and histological study of rat liver and kidney injury induced by Cisplatin. J Toxicol Pathol 2013; 26:293-9.
24. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 2007;226: 157-67.
25. Satoh M, Kashihara N, Fujimoto S, et al. A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther 2003;305: 1183-90.
26. Palipoch S, Punsawad C, Koomhin P, Suwannalert P. Hepatoprotective effect of curcumin and alpha-tocopherol against cisplatin-induced oxidative stress. BMC Complement Altern Med 2014;14:111.
27. Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 2004;195:221-30.
28. Rezvanfar MA, Rezvanfar MA, Shahverdi AR, et al. Protection of cisplatin-induced spermatotoxicity, DNA damage and chromatin abnormality by selenium nano-particles. Toxicol Appl Pharmacol 2013;266:356-65.
29. Altuner D, Gulaboglu M, Yapca OE, Cetin N. The effect of mirtazapine on cisplatin-induced oxidative damage and infertility in rat ovaries. ScientificWorldJournal 2013;2013:327240.
30. Beheshtian A, Salmasi AH, Payabvash S, et al. Protective effects of sildenafil administration on testicular torsion/detorsion damage in rats. World J Urol 2008;26:197-202.
31. Yldz H, Durmus AS, Simsek H, Yaman M. Dose-dependent protective effect of sildenafil citrate on testicular injury after torsion/detorsion in rats. Andrologia 2012;44:300-6.
32. Yildiz H, Durmųs AS, Simsek H, Yaman I. Effects of sildenafil citrate on torsion/detorsion-induced changes in red blood cell and plasma lipid peroxidation, antioxidants, and blood hematology of male rats. Eur J Obstet Gynecol Reprod Biol 2011;159: 359-63.